A Long-Term Extension Trial in Participants With Atopic Dermatitis Who Participated in Previous EDP1815 Trials
Public ClinicalTrials.gov record NCT05439941. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Long-Term Extension Trial in Participants With Atopic Dermatitis Who Participated in Previous Phase 2 And 3 EDP1815 Trials
Study identification
- NCT ID
- NCT05439941
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Evelo Biosciences, Inc.
- Industry
- Enrollment
- 287 participants
Conditions and interventions
Conditions
Interventions
- EDP1815 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 76 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 5, 2022
- Primary completion
- May 24, 2023
- Completion
- Jun 6, 2023
- Last update posted
- Sep 6, 2023
2022 – 2023
United States locations
- U.S. sites
- 24
- U.S. states
- 12
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| USA-131 | Birmingham | Alabama | 35244 | — |
| USA 112 | Fountain Valley | California | 92708 | — |
| USA 123 | Fremont | California | 94538 | — |
| USA -101 | Fort Lauderdale | Florida | 33308 | — |
| USA-124 | Jacksonville | Florida | 32216 | — |
| USA-108 | Miami | Florida | 33165 | — |
| USA-120 | Miami | Florida | 33175 | — |
| USA-105 | Miramar | Florida | 33027 | — |
| USA-102 | Orlando | Florida | 32801 | — |
| USA-115 | Sweetwater | Florida | 33172 | — |
| USA-106 | Tampa | Florida | 33613 | — |
| USA-126 | Tampa | Florida | 33613 | — |
| USA-111 | Clarksville | Indiana | 47129 | — |
| USA-116 | Louisville | Kentucky | 40241 | — |
| USA-119 | Baton Rouge | Louisiana | 70806 | — |
| USA-109 | Metairie | Louisiana | 70006 | — |
| USA-125 | Silver Spring | Maryland | 20902 | — |
| USA-121 | Columbus | Ohio | 43221 | — |
| USA-128 | Concord | Ohio | 44077 | — |
| USA-104 | Portland | Oregon | 97239 | — |
| USA-127 | Memphis | Tennessee | 38119 | — |
| USA-117 | Frisco | Texas | 75034 | — |
| USA-110 | Pflugerville | Texas | 78660 | — |
| USA-113 | Bellevue | Washington | 98004 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 30 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05439941, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 6, 2023 · Synced Jun 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05439941 live on ClinicalTrials.gov.